For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231116:nRSP7523Ta&default-theme=true
RNS Number : 7523T Centrica PLC 16 November 2023
Transactions in own shares
Centrica plc
16 November 2023
Centrica plc announces that today it purchased (through Goldman Sachs
International) 1,355,014 Centrica plc ordinary shares of 6 (14)/(81) pence
each at a price of 149.5100 pence per share. The purchased shares will be held
as treasury shares. Such purchase was effected pursuant to the Company's
buyback programme announced on 10 October 2023 and in accordance with the
non-discretionary share repurchase agreement entered into with Goldman Sachs
International, as announced on 10 October 2023.
Since 10 October 2023, Centrica has purchased 35,301,492 ordinary shares at a
cost (excluding dealing and associated costs) of £54,730,333.98.
Following the above purchase, Centrica plc holds 455,778,103 ordinary shares
in treasury, and has 5,452,068,035 ordinary shares in issue (excluding
treasury shares).
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market
Abuse Regulation) (as in force in the UK and as amended by the Market Abuse
(Amendment) (EU Exit) Regulations 2019), detailed information about the
individual purchases made by Goldman Sachs International is set out below.
Transaction details: Centrica plc ordinary shares of 6 (14)/(81) pence each
Issuer name: Centrica plc
ISIN: GB00B033F229
Intermediary name: Goldman Sachs International
Intermediary Code: GSILGB2XXXX
Currency: GBP
Aggregated information
Date of purchase: 16 November 2023
Number of ordinary shares purchased: 1,355,014
Highest price paid: 150.6000p
Lowest price paid: 148.4500p
Volume weighted average price paid per share: 149.5100p
Disaggregated information
The table attached contains detailed information of the individual trades made
by Goldman Sachs International, as part of the buyback programme.
Click on, or paste the following link into your web browser, to view the
associated PDF document.
http://www.rns-pdf.londonstockexchange.com/rns/7523T_1-2023-11-16.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/7523T_1-2023-11-16.pdf)
END
Enquiries:
Investors and Analysts
T: 01753 494900
E: ir@centrica.com
Centrica plc is listed on the London Stock Exchange (CNA)
Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD
Registered in England & Wales number: 3033654
Legal Entity Identifier number: E26EDV109X6EEPBKVH76
ISIN number: GB00B033F229
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSKZMMMNVNGFZM